About One Nucleus
One Nucleus is a Government & Social Sector company based in United Kingdom founded in 2008. One Nucleus is recognized as a not-for-profit Life Sciences Healthcare membership organization headquartered in Cambridge, supporting connectivity and growth in the sector. It operates on a Membership Organization model. Its website onenucleus.com draws about 10 thousand monthly visits. One Nucleus offers products and services including Membership Services, Training Courses, and Networking Events. Its focus areas include Healthcare, Life Sciences and Support Services. Its legal entity is One Nucleus Limited.
Company details
One Nucleus is established as a not-for-profit membership organization focused on Life Sciences and Healthcare, with headquarters in Cambridge, United Kingdom. The organization is dedicated to supporting institutions, companies, and individuals by providing local, UK-wide, and international connectivity. Services are offered in the form of membership benefits, training courses, networking events, and opportunities for raising profiles within the Greater Cambridge cluster and beyond. Sectors served include life sciences and healthcare, with solutions aimed at fostering collaboration, knowledge exchange, and talent development to enhance the reputation and success of the industry.
- Headquarters United Kingdom
- SectorsGovernment & Social Sector
- Website category Health · Biotechnology and Pharmaceuticals
- Phone•••• ••••
- Website onenucleus.com
- Social LinkedIn X YouTube
- Legal Name One Nucleus Limited
- Latest Funding Round$132.84K (USD), Grant
Feb 2022
- Investors
Products & Services of One Nucleus
One Nucleus offers a comprehensive portfolio of products and services, including Membership Services, Training Courses, and Networking Events.
Membership services are provided to support institutions, companies, and individuals in the Life Sciences sector with local, UK-wide, and international connectivity.
Training courses are offered both in-person and online to meet the needs of member organizations and their employees in the Life Sciences sector.
Networking events are organized to connect members with potential partners, investors, service providers, and peers for knowledge-sharing.
Apps and channels of One Nucleus
its YouTube channel OneNucleus has 318 subscribers.
Funding Insights of One Nucleus
- Total Rounds 1
- Last Round Grant — $132,839
- First Round $132,839
(Feb 2022)
- Investors Count 1
All 1 funding rounds of One Nucleus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2022 | $132,839 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in One Nucleus
One Nucleus has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for One Nucleus
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of One Nucleus
2 dated milestones of One Nucleus across 14 years, from founding to its latest funding, stage changes and deals.
- Founded One Nucleus is founded.
- Funding First funding round of $133K.
Web traffic of One Nucleus
The website of One Nucleus (onenucleus.com) receives about 10.2K visits a month and ranks #571,136 among all websites worldwide, #595 in Biotechnology and Pharmaceuticals.
- Monthly visits10.2K
▼ 18.7% vs previous month
- Unique visitors4.9K
per month
- Global rank#571,136
among all websites
- Category rank#595
Health · Biotechnology and Pharmaceuticals
- Bounce rate41%
- Pages per visit53.6
- Average visit11 min 36 sec
- DevicesDesktop 61% · Mobile 39%
Websites whose visitors overlap most with One Nucleus. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| alderleypark.co.uk | 100% | 3.2K | #5,166,095 | View details | |
| merckgroup.com | 59% | 910.8K | #54,804 | View details | |
| astrazeneca.com | 58% | 1.3M | #48,983 | View details | |
| nucleusfinancial.com | 21% | 82.7K | #455,344 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about One Nucleus
One Nucleus was founded in 2008 and raised its 1st funding round 14 years after it was founded.
One Nucleus is headquartered in United Kingdom.
One Nucleus is established as a not-for-profit membership organization focused on Life Sciences and Healthcare, with headquarters in Cambridge, United Kingdom. The organization is dedicated to supporting institutions, companies, and individuals by providing local, UK-wide, and international connectivity. Services are offered in the form of membership benefits, training courses, networking events, and opportunities for raising profiles within the Greater Cambridge cluster and beyond. Sectors served include life sciences and healthcare, with solutions aimed at fostering collaboration, knowledge exchange, and talent development to enhance the reputation and success of the industry.
One Nucleus offers Membership Services, Training Courses, and Networking Events.
One Nucleus has 1 investor. Key investors include European Union.
One Nucleus operates through One Nucleus Limited.